Revvity, Inc. (RVTY)
131.00
+4.41
(+3.48%)
USD |
NYSE |
Sep 02, 14:16
Revvity Research and Development Expense (Annual) : 215.84M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 215.84M |
| December 31, 2024 | 196.84M |
| December 31, 2023 | 216.58M |
| December 31, 2022 | 221.62M |
| December 31, 2021 | 200.34M |
| December 31, 2020 | 205.39M |
| December 31, 2019 | 189.34M |
| December 31, 2018 | 186.10M |
| December 31, 2017 | 139.16M |
| December 31, 2016 | 123.78M |
| December 31, 2015 | 112.04M |
| December 31, 2014 | 120.54M |
| December 31, 2013 | 132.52M |
| December 31, 2012 | 132.14M |
| December 31, 2011 | 115.12M |
| December 31, 2010 | 93.81M |
| December 31, 2009 | 90.78M |
| December 31, 2008 | 108.94M |
| December 31, 2007 | 109.92M |
| December 31, 2006 | 98.12M |
| December 31, 2005 | 87.37M |
| December 31, 2004 | 82.36M |
| December 31, 2003 | 83.14M |
| Date | Value |
|---|---|
| December 31, 2002 | 86.45M |
| December 31, 2001 | 81.32M |
| December 31, 2000 | 86.12M |
| December 31, 1999 | 71.25M |
| December 31, 1998 | 46.03M |
| December 31, 1997 | 44.91M |
| December 31, 1996 | 42.84M |
| December 31, 1995 | 42.38M |
| December 31, 1994 | 38.58M |
| December 31, 1993 | 34.70M |
| December 31, 1992 | 32.10M |
| December 31, 1991 | 24.70M |
| December 31, 1990 | 23.10M |
| December 31, 1989 | 18.50M |
| December 31, 1988 | 20.20M |
| December 31, 1987 | 17.80M |
| December 31, 1986 | 16.40M |
| December 31, 1985 | 16.80M |
| December 31, 1984 | 14.70M |
| December 31, 1983 | 12.90M |
| December 31, 1982 | 11.40M |
| December 31, 1981 | 10.50M |
| December 31, 1980 | 10.40M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Agilent Technologies, Inc. | 450.00M |
| Thermo Fisher Scientific, Inc. | 1.397B |
| Danaher Corp. | 1.598B |
| Waters Corp. | 195.18M |
| Bio-Rad Laboratories, Inc. | 257.60M |